GlassScriptPhysician profile
Elizabeth Ann Braun
NPI 1861748329
$7,687.66
in general payments reported to CMS, 2019-2025
21 companies · $4,062 in 2025
The $4,062 reported for 2025 was more than what 99% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,097 · 2020: $215 · 2021: $130 · 2022: $539 · 2023: $272 · 2024: $1,372 · 2025: $4,062.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,526 · Travel and Lodging: $985 · Education: $97.99 · Entertainment: $96.89.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,526.12 |
| Travel and Lodging | $985.36 |
| Education | $97.99 |
| Entertainment | $96.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $2,950.72 | 2024-2025 | |
| Bausch & Lomb Americas INC. | $858.64 | 2022-2025 | Miebo, Xiidra |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $578.17 | 2019-2021 | |
| Harrow Eye, LLC | $483.53 | 2024-2025 | Vevye, Iheezo |
| Alcon Vision LLC | $426.79 | 2019-2025 | Tryptyr, Eysuvis, Rocklatan |
| Sun Pharmaceutical Industries INC. | $319.68 | 2023-2025 | Cequa |
| Tarsus Pharmaceuticals, INC. | $260.74 | 2024-2025 | Xdemvy |
| Oyster Point Pharma, INC. | $252.94 | 2022-2025 | Tyrvaya, Ryzumvi, Ryzumvi |
| Mallinckrodt Hospital Products INC. | $221.01 | 2022-2025 | Acthar |
| Dompe US, INC. | $202.84 | 2024-2025 | Oxervate |
| Optos, INC. | $196.49 | 2019-2023 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Abbvie INC. | $196.35 | 2022-2025 | Alphagan P, Lumigan |
| Amgen INC. | $156.08 | 2024-2025 | Tepezza |
| Coopervision INC. | $151.78 | 2019-2024 | Myday Contact Lens |
| Johnson & Johnson Vision Care, INC. | $146.27 | 2019-2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $123.63 | 2019 | |
| Alcon Research LLC | $43.05 | 2019 | |
| Novartis Pharmaceuticals Corporation | $40.36 | 2022 | |
| Horizon Therapeutics Plc | $36.03 | 2022-2023 | Tepezza |
| Rayner Intraocular Lenses Limited | $22.28 | 2025 | Rayone Aspheric, Rayone Emv, Rayner Cataract Set 1 |
| Aerie Pharmaceuticals, INC. | $20.28 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elizabeth Braun listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.